Piermont Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-165,569
| Closed | -$505K | – | 271 |
|
|
2016
Q4 | $505K | Sell |
165,569
-3,510
| -2% | -$10.7K | 0.12% | 224 |
|
|
2016
Q3 | $783K | Buy |
169,079
+14,460
| +9% | +$67K | 0.19% | 188 |
|
|
2016
Q2 | $895K | Buy |
154,619
+74,050
| +92% | +$429K | 0.23% | 172 |
|
|
2016
Q1 | $487K | Buy |
+80,569
| New | +$487K | 0.16% | 147 |
|
|
2015
Q2 | – | Sell |
-48,430
| Closed | -$759K | – | 251 |
|
|
2015
Q1 | $759K | Buy |
48,430
+16,220
| +50% | +$254K | 0.23% | 108 |
|
|
2014
Q4 | $490K | Buy |
32,210
+8,040
| +33% | +$122K | 0.17% | 106 |
|
|
2014
Q3 | $261K | Buy |
+24,170
| New | +$261K | 0.1% | 181 |
|